Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Artiva Biotherapeutics Announces Pricing of $300 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
-
Artiva Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights
-
VANCOUVER, British Columbia, May 05, 2026 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology solution provider specializing in AI (Artificial...
-
A submission into a U.S. DoW critical minerals solicitation, an inbound IR engagement targeting the European market, and a flow-through financing arrive in the middle of a tungsten supercycle — and 8...
-
VANCOUVER, British Columbia, April 29, 2026 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA | FSE: 49Q | BMV: ZENA) (“ZenaTech” or the “Company”), a technology company specializing in AI-powered...
-
New York, USA, April 28, 2026 (GLOBE NEWSWIRE) -- Global AAV Vector Manufacturing Market Gearing Up for Outstanding Expansion at a CAGR of ~22% by 2034 | DelveInsight The AAV vector manufacturing...
-
Reborn Coffee Provides Full Year 2025 Corporate Update and Financial Results
-
Exicure enters co-development agreement with Adbiotech to advance Burixafor (GPC-100) combination therapies across multiple indications.
-
ANCHORAGE, Alaska, April 22, 2026 (GLOBE NEWSWIRE) -- Northrim BanCorp, Inc. (NASDAQ:NRIM) (“Northrim” or the “Company”) today reported net income of $13.7 million, or $0.61 per diluted share, in...
-
ZenaTech Continues International Expansion Opening New Offices in South Korea and the United Kingdom
ZenaTech Continues International Expansion Opening New Offices in South Korea and the United Kingdom